Huons Global Co., Ltd. (084110.KQ)
KRW 52100.0
(3.99%)
KRW 52100.0
(3.99%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 66.94 Billion KRW | -5.48% |
| 2022 | 70.82 Billion KRW | 3.34% |
| 2021 | 68.53 Billion KRW | 59.25% |
| 2020 | 43.03 Billion KRW | 125.81% |
| 2019 | 19.05 Billion KRW | -13.0% |
| 2018 | 21.9 Billion KRW | 21.47% |
| 2017 | 18.03 Billion KRW | 57.35% |
| 2016 | 11.46 Billion KRW | 324.49% |
| 2015 | 2.7 Billion KRW | -50.91% |
| 2014 | 5.49 Billion KRW | -66.97% |
| 2013 | 16.65 Billion KRW | -47.46% |
| 2012 | 31.69 Billion KRW | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 71.4 Billion KRW | 1.62% |
| 2024 Q1 | 70.26 Billion KRW | 4.97% |
| 2023 FY | 66.94 Billion KRW | -5.48% |
| 2023 Q3 | 65 Billion KRW | 0.0% |
| 2023 Q2 | 65 Billion KRW | 0.0% |
| 2023 Q1 | 65 Billion KRW | -8.23% |
| 2023 Q4 | 66.94 Billion KRW | 2.99% |
| 2022 Q4 | 70.82 Billion KRW | -20.61% |
| 2022 Q1 | 73.27 Billion KRW | 6.91% |
| 2022 Q2 | 75.83 Billion KRW | 3.49% |
| 2022 Q3 | 89.21 Billion KRW | 17.65% |
| 2022 FY | 70.82 Billion KRW | 3.34% |
| 2021 Q1 | 44.16 Billion KRW | -1.46% |
| 2021 Q2 | 73.17 Billion KRW | 65.69% |
| 2021 Q3 | 74.77 Billion KRW | 2.18% |
| 2021 Q4 | 68.53 Billion KRW | -8.34% |
| 2021 FY | 68.53 Billion KRW | 59.25% |
| 2020 FY | 43.03 Billion KRW | 125.81% |
| 2020 Q1 | 10.03 Billion KRW | -51.92% |
| 2020 Q3 | 12.57 Billion KRW | 30.22% |
| 2020 Q4 | 44.82 Billion KRW | 256.42% |
| 2020 Q2 | 9.65 Billion KRW | -3.78% |
| 2019 FY | 19.05 Billion KRW | -13.0% |
| 2019 Q2 | 24.1 Billion KRW | 1.49% |
| 2019 Q4 | 20.87 Billion KRW | -11.35% |
| 2019 Q1 | 23.75 Billion KRW | 8.44% |
| 2019 Q3 | 23.54 Billion KRW | -2.33% |
| 2018 Q2 | 28.15 Billion KRW | 2.04% |
| 2018 Q4 | 21.9 Billion KRW | -18.01% |
| 2018 Q3 | 26.71 Billion KRW | -5.09% |
| 2018 Q1 | 27.58 Billion KRW | 52.99% |
| 2018 FY | 21.9 Billion KRW | 21.47% |
| 2017 Q1 | 18.22 Billion KRW | 58.99% |
| 2017 Q2 | 20.91 Billion KRW | 14.8% |
| 2017 Q3 | 19.47 Billion KRW | -6.9% |
| 2017 FY | 18.03 Billion KRW | 57.35% |
| 2017 Q4 | 18.03 Billion KRW | -7.41% |
| 2016 Q1 | 2.47 Billion KRW | -8.33% |
| 2016 FY | 11.46 Billion KRW | 324.49% |
| 2016 Q4 | 11.46 Billion KRW | -8.95% |
| 2016 Q3 | 12.58 Billion KRW | 459.46% |
| 2016 Q2 | 2.25 Billion KRW | -9.09% |
| 2015 FY | 2.7 Billion KRW | -50.91% |
| 2015 Q4 | 2.7 Billion KRW | -42.86% |
| 2015 Q3 | 4.72 Billion KRW | -4.55% |
| 2015 Q2 | 4.95 Billion KRW | -4.35% |
| 2015 Q1 | 5.17 Billion KRW | -5.91% |
| 2014 Q1 | 14.89 Billion KRW | -10.55% |
| 2014 FY | 5.49 Billion KRW | -66.97% |
| 2014 Q3 | 8.18 Billion KRW | -4.11% |
| 2014 Q4 | 5.49 Billion KRW | -32.78% |
| 2014 Q2 | 8.53 Billion KRW | -42.72% |
| 2013 Q2 | 16.05 Billion KRW | -48.57% |
| 2013 Q1 | 31.21 Billion KRW | -1.51% |
| 2013 Q4 | 16.65 Billion KRW | 19.06% |
| 2013 Q3 | 13.98 Billion KRW | -12.89% |
| 2013 FY | 16.65 Billion KRW | -47.46% |
| 2012 FY | 31.69 Billion KRW | 0.0% |
| 2012 Q4 | 31.69 Billion KRW | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| HLB Pharmaceutical Co., Ltd | 988.75 Million KRW | -6670.454% |
| CMG Pharmaceutical Co., Ltd. | 19.06 Billion KRW | -251.15% |
| Celltrion Pharm, Inc. | 4.33 Billion KRW | -1444.852% |
| DongKook Pharmaceutical Co., Ltd. | 18.74 Billion KRW | -257.033% |
| Enzychem Lifesciences Corporation | 1.02 Billion KRW | -6431.052% |
| Humedix Co., Ltd. | 1.75 Billion KRW | -3713.716% |
| Boditech Med Inc. | 2.09 Billion KRW | -3087.866% |
| EuBiologics Co., Ltd. | 2.8 Billion KRW | -2290.831% |
| FutureChem Co.,Ltd | 2.61 Billion KRW | -2455.287% |
| Huons Co., Ltd. | 58.35 Billion KRW | -14.727% |
| BNC Korea Co., Ltd. | 301.69 Million KRW | -22089.409% |
| AptaBio Therapeutics Inc. | 13.56 Billion KRW | -393.338% |